GE HealthCare Names New CFO — William K. Grogan

The CFO role at GE HealthCare carries immediate strategic and operational responsibilities tied to the company’s stated priorities. GE HealthCare reported total revenues of $20,625 million for 2025 with a four-segment operating model (Imaging, AVS, PCS, PDx). Investors will watch how the incoming CFO supports the agenda to accelerate organic revenue, protect margins and expand recurring/digital revenue. Key near-term investor considerations rooted in company disclosures include: tariff and macro exposure (2025 operating income was impacted by $245 million from tariffs), China market headwinds due to local competition and procurement policies, and segment performance dispersion—PDx and AVS showed higher margins (approximately 30% and 22% respectively) while PCS margins declined. These are direct financial levers the new CFO will inherit when he assumes the role on Sept. 14, 2026.

Based on GE HealthCare’s published strategy and 2025 results, practical priorities for the new CFO (derived from company guidance and filings) are likely to include: mitigating tariff-related cost pressure, supporting margin resilience across Imaging and PCS, allocating capital to high-margin PDx and AVS growth areas, and advancing the shift toward recurring digital/SaaS revenue. Specific metrics investors may track after the appointment include adjusted EBIT and adjusted net income trends (2025 adjusted EBIT was $3,155 million and adjusted net income $2,100 million), progress on organic revenue growth targets, and any updates tied to the company’s long-term incentive framework that emphasizes organic revenue and adjusted EPS. The new finance chief will also play a central role in managing geopolitical and regulatory risks highlighted by the company, including exposures tied to international operations.